Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05165433
Title Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY) (FORTIFY)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors PsiOxus Therapeutics Ltd
Indications

carcinoma

adenocarcinoma

Therapies

NG-350A + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Recruiting Santa Monica California 90404 United States Details
MD Anderson Cancer Centre Recruiting Houston Texas 77030 United States Details
Clatterbridge Cancer Centre Not yet recruiting Liverpool CH63 4JY United Kingdom Details
Churchill Hospital Not yet recruiting Oxford OX3 7LE United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field